Although tumor tissue biomarkers like tumor PD-L1 expression, tumor mutational burden (TMB), mismatch repair protein (MMR), and microsatellite instability (MSI) are promising, they are limited by the tumor microenvironment’s complexity and their lack of specificity and accuracy [6, 7]. The gene discussed is MRC1; the disease is neoplasm.